- NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.
Request or activate your NovoLog® Savings Offer
If you have commercial insurance, such as insurance you receive through an employer, you may be eligible to pay as little as $35 per 30-day supply (maximum savings up to $65 per 30-day supply) or pay no more than $99 for up to 24 months.a
Want to register via text and save your Novo Nordisk Savings Offer to your phone? Text SAVE to 97430 to sign up.b,c
¿Habla español? Por favor, llame al 1-877-304-6852 para inscribirse.
aEligibility and other restrictions apply.
bSee terms and conditions of use.
cMessage and data rates may apply. Check with your mobile service provider. Message frequency varies. Text HELP to 97430 for help. Text STOP to 97430 to quit. See Privacy Policy.
Request or activate your NovoLog® Savings Offer
If you have commercial insurance, such as insurance you receive through an employer, you may be eligible to pay as little as $35 per 30-day supply (maximum savings up to $65 per 30-day supply) or pay no more than $99 for up to 24 months.a
Want to register via text and save your Novo Nordisk Savings Offer to your phone? Text SAVE to 97430 to sign up.b,c
¿Habla español? Por favor, llame al 1-877-304-6852 para inscribirse.
aEligibility and other restrictions apply.
bSee terms and conditions of use.
cMessage and data rates may apply. Check with your mobile service provider. Message frequency varies. Text HELP to 97430 for help. Text STOP to 97430 to quit. See Privacy Policy.
Request or activate your NovoLog® Savings Card
NovoLog® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.
Cornerstones4Care®, FlexPen®, FlexTouch®, NovoCare®, NovoLog®, NovoPen Echo®, and PenFill® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2023 Novo Nordisk All rights reserved. US22NC00088 January 2023